Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reverse add-back protocol after endometriosis surgery
ChiCTR2600124622Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in endometriosis comparing Low-dose estradiol + dydrogesterone with Tibolone (2 arms). Primary endpoint: Modified Menopause Index score. Planned start May 2026; status: not yet recruiting.
02
Drugs
estradiol + dydrogesteronetibolone
03
Conditions
endometriosis
Beyond the preview
Go deeper on ChiCTR2600124622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124622.